跳至主要内容
临床试验/NCT01755455
NCT01755455已完成不适用

Iron Supplementation for the Hypoferremic Anemia of Cystic Fibrosis

Dartmouth-Hitchcock Medical Center2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Change From Baseline in Hemoglobin Concentration (gm/dl)

研究概览

简要总结

This study questions whether low-dose ferrous sulfate taken by mouth daily for 6 weeks increases hemoglobin concentration in adult subjects with cystic fibrosis and hypoferremic anemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of Pseudomonas aeruginosa colonization of the lung
  • Transferrin saturation (TSAT) less than or equal to 21%
  • Hemoglobin concentration <15.5 gm/dl (men)
  • Hemoglobin concentration <13.6 gm/dl (women)

排除标准

  • Use of iron-containing vitamin or supplement
  • Pregnancy
  • Lactation
  • Cirrhosis
  • History of chronic visible (gross) hemoptysis
  • Hereditary hemochromatosis
  • History of transfusion-related iron overload
  • Use of iron chelator(s)
  • Withdrawal of informed consent
  • Contraindication to phlebotomy

研究组 & 干预措施

Ferrous sulfate 325mg

Active Comparator

Ferrous sulfate 325mg tablet taken by mouth daily for 6 weeks

干预措施: Ferrous sulfate 325mg (Drug)

Placebo

Placebo Comparator

Identical-appearing tablet taken by mouth daily for 6 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Baseline in Hemoglobin Concentration (gm/dl)

时间窗: Baseline and 6 weeks

次要结局

  • Change From Baseline in Serum Iron (mcg/dl)(Baseline and 6 weeks)
  • Change From Baseline in Transferrin Saturation (%)(Baseline and 6 weeks)
  • Change From Baseline in Sputum Iron (ng/mg)(Baseline and 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alex H. Gifford

Assistant Professor of Medicine

Dartmouth-Hitchcock Medical Center

研究点 (2)

Loading locations...

相似试验